Home
>
National Drug Code (NDC)
>
Diamox Sequels
Diamox Sequels - 51285-754-02 - (Acetazolamide)
Drug Information of Diamox Sequels
| Product NDC: | 51285-754 |
| Proprietary Name: | Diamox Sequels |
| Non Proprietary Name: | Acetazolamide |
| Active Ingredient(s): | 500 mg/1 & nbsp; Acetazolamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Diamox Sequels
| Product NDC: | 51285-754 |
| Labeler Name: | Duramed Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012945 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19620301 |
Package Information of Diamox Sequels
| Package NDC: | 51285-754-02 |
| Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51285-754-02) |
NDC Information of Diamox Sequels
| NDC Code | 51285-754-02 |
| Proprietary Name | Diamox Sequels |
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51285-754-02) |
| Product NDC | 51285-754 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acetazolamide |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19620301 |
| Marketing Category Name | NDA |
| Labeler Name | Duramed Pharmaceuticals, Inc. |
| Substance Name | ACETAZOLAMIDE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA],Sulfonamides [Chemical/Ingredient] |
